Membrane-Based Approach for the Downstream Processing of Influenza Virus-Like Particles.

作者: Sofia B Carvalho , Ricardo JS Silva , Mafalda G Moleirinho , Bárbara Cunha , Ana S Moreira

DOI: 10.1002/BIOT.201800570

关键词:

摘要: Currently, marketed influenza vaccines are only efficient against homologous viruses, thus requiring a seasonal update based on circulating subtypes. This constant reformulation adds several challenges to manufacturing, particularly in purification due the variation of physicochemical properties vaccine product. A universal platform approach capable handling such is therefore utmost importance. In this work, filtration-based explored purify virus-like particles. Switching from adsorptive separation size-based allows overcoming differences retention observed for different strains. The proposed process employs cascade ultrafiltration and diafiltration steps, followed by sterile filtration step. Different parameters assessed terms product recovery impurities' removal. Membrane chemistry, pore size, operation modes, critical flux, transmembrane pressure, permeate control strategies evaluated. After membrane selection parameter optimization, concentration factors volumes also defined. By optimizing mode operation, it possible achieve recoveries approximately 80%. Overall, time decreased 30%, its scalability improved, costs reduced removal chromatography associated buffer consumptions, cleaning, validation steps.

参考文章(33)
Christine M Thompson, Emma Petiot, Alaka Mullick, Marc G Aucoin, Olivier Henry, Amine A Kamen, Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems. BMC Biotechnology. ,vol. 15, pp. 31- 31 ,(2015) , 10.1186/S12896-015-0152-X
Fabien Pitoiset, Thomas Vazquez, Bertrand Bellier, Enveloped virus-like particle platforms: vaccines of the future? Expert Review of Vaccines. ,vol. 14, pp. 913- 915 ,(2015) , 10.1586/14760584.2015.1046440
Piergiuseppe Nestola, Cristina Peixoto, Ricardo R. J. S Silva, Paula M. Alves, José P. B. Mota, Manuel J. T. Carrondo, Improved virus purification processes for vaccines and gene therapy Biotechnology and Bioengineering. ,vol. 112, pp. 843- 857 ,(2015) , 10.1002/BIT.25545
Peter Pushko, Irina Tretyakova, Rachmat Hidajat, Garrett Hamilton, Noah Horn, Brian Nickols, Raphael O. Prather, Terrence M. Tumpey, Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein. Virology. ,vol. 487, pp. 163- 171 ,(2016) , 10.1016/J.VIROL.2015.10.007
John O. Konz, Rebecca C. Livingood, Andrew J. Bett, Aaron R. Goerke, Michael E. Laska, Sangeetha L. Sagar, Serotype specificity of adenovirus purification using anion-exchange chromatography. Human Gene Therapy. ,vol. 16, pp. 1346- 1353 ,(2005) , 10.1089/HUM.2005.16.1346
Lars Opitz, Jonas Hohlweg, Udo Reichl, Michael W. Wolff, Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. Journal of Virological Methods. ,vol. 161, pp. 312- 316 ,(2009) , 10.1016/J.JVIROMET.2009.06.025
M.P. Watson, M.A. Winters, S.L. Sagar, J.O. Konz, Sterilizing filtration of plasmid DNA: effects of plasmid concentration, molecular weight, and conformation. Biotechnology Progress. ,vol. 22, pp. 465- 470 ,(2006) , 10.1021/BP050280S
Emily M. Plummer, Marianne Manchester, Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. ,vol. 3, pp. 174- 196 ,(2011) , 10.1002/WNAN.119
R Morenweiser, Downstream processing of viral vectors and vaccines. Gene Therapy. ,vol. 12, ,(2005) , 10.1038/SJ.GT.3302624
Steven M Cramer, Melissa A Holstein, Downstream bioprocessing: recent advances and future promise Current Opinion in Chemical Engineering. ,vol. 1, pp. 27- 37 ,(2011) , 10.1016/J.COCHE.2011.08.008